|
Information For:
|
Erratum to Mannitol Injection MonographJuly 2, 2008This erratum corrects the Labeling statement published in USP31-NF26. A revision to the Labeling statement was originally intended to become official on January 1, 2006. This official date of this revision was subsequently postponed to August 1, 2007 via an Interim Revision Announcement published in Pharmacopeial Forum 32(2) [Mar-April 2006]. The correct Labeling statement is:
This Labeling statement was published in USP30-NF25, however, the underlined portion of the statement was inadvertently omitted from hard copy and electronic versions of USP31-NF26. The erratum to be published in Pharmacopeial Forum 34(4) [July-Aug 2008] presents the correct labeling statement as stated above. Download the correct Mannitol Injection monograph We apologize for this error and provide here a corrected PDF of Mannitol Injection. The correct Labeling statement will be included in the USP32-NF27. Please contact Dr. Sujatha Ramakrishna () if there are any questions. What's NewChanges to the Dissolution Performance Verification Test (11/20/09) PF 35(6) Errata (10/30/09) New official Text for October: 15 Revisions Bulletins (10/30/09) Pending Standards for the month of October (10/30/09) PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09) Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09) Elemental Impurities Hot Topics information updated (10/13/09) General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09) Heparin Hot Topics information updated (10/02/09)
Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||